Relationship between lipoprotein concentrations and short-term and 1-year mortality in intensive care unit septic patients: results from the HIGHSEPS study

Reconstituted High-density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis

(2020) Sébastien Tanaka et al.   ANESTHESIOLOGY

Impact of the pre-illness lipid profile on sepsis mortality

(2020) Michael D. Maile et al.   JOURNAL OF CRITICAL CARE

High-Density Lipoproteins Are Bug Scavengers

(2020) Olivier Meilhac et al.   Biomolecules

High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients

(2019) Sébastien Tanaka et al.   Annals of Intensive Care

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease

(2019) Mark Trinder et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock

(2018) Faheem W. Guirgis et al.   PLoS One

Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis

(2018) Mark Trinder et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Low Low-Density Lipoprotein Levels Are Associated With, But Do Not Causally Contribute to, Increased Mortality in Sepsis

(2018) Keith R. Walley et al.   CRITICAL CARE MEDICINE

Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis

(2017) Mihai Cirstea et al.   JOURNAL OF CRITICAL CARE

Two-year follow-up of patients with septic shock presenting with low HDL: the effect upon acute kidney injury, death and estimated glomerular filtration rate

(2017) K. Roveran Genga et al.   JOURNAL OF INTERNAL MEDICINE

Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients with Sepsis

(2017) Faheem W. Guirgis et al.   SHOCK

Low HDL levels in sepsis versus trauma patients in intensive care unit

(2017) Sébastien Tanaka et al.   Annals of Intensive Care

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   EUROPEAN HEART JOURNAL

PCSK9 inhibitors in sepsis: a new potential indication?

(2016) Amir Abbas Momtazi et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor

(2016) Elena Topchiy et al.   PLoS One

Recombinant HDL (Milano) protects endotoxin-challenged rats from multiple organ injury and dysfunction

(2015) Xinbo Zhang et al.   BIOLOGICAL CHEMISTRY

Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis

(2014) Alexandra Lekkou et al.   JOURNAL OF CRITICAL CARE

PCSK9 is a critical regulator of the innate immune response and septic shock outcome

(2014) K. R. Walley et al.   Science Translational Medicine

HDL and endothelial protection

(2013) A Tran-Dinh et al.   BRITISH JOURNAL OF PHARMACOLOGY

Severe Sepsis and Septic Shock

(2013) Derek C. Angus et al.   NEW ENGLAND JOURNAL OF MEDICINE

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats

(2010) Lijun Dai et al.   JOURNAL OF LIPID RESEARCH

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

(2010) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk

(2009) M.T. Cooney et al.   ATHEROSCLEROSIS

Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation

(2009) Stefan Barlage et al.   INTENSIVE CARE MEDICINE